NEU neuren pharmaceuticals limited

Ann: Neuren appoints Joe Basile to board of directors, page-5

  1. 6,289 Posts.
    lightbulb Created with Sketch. 22300
    Around this time last year we had the appointment of Gerry Zhao as VP of Corporate Development to “work with CEO Jon Pilcher on all partnering, M&A and investor activities”.
    Gerry has deep connections in Asia, especially China.

    Today we have the appointment of Joe Basile as a Non-Executive Director. Joe is said to have “deep experience in corporate mergers and acquisitions, capital management and overseeing expansion activities across multiple countries”.

    Joe is currently CFO for the iNova Group, which is based in Singapore but covers predominantly Asia and ANZ. He previously worked as Finance Director for Novartis, again in Asia and ANZ.

    Interesting that both M&A partnering and capital management appointees have deep networks in Asia, rather than the US or Europe. A sign of future direction?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.91
Change
-0.050(0.39%)
Mkt cap ! $1.609B
Open High Low Value Volume
$12.82 $13.05 $12.70 $2.503M 193.8K

Buyers (Bids)

No. Vol. Price($)
8 570 $12.90
 

Sellers (Offers)

Price($) Vol. No.
$12.92 438 17
View Market Depth
Last trade - 13.43pm 17/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.